Results 231 to 240 of about 16,340 (253)
Some of the next articles are maybe not open access.
Radioembolization for Hepatocellular Carcinoma
Digestive Disease Interventions, 2021AbstractHepatocellular carcinoma (HCC) is the fastest-growing cancer worldwide, causing significant morbidity and mortality. Surgical resection, ablation, or transplantation is the best treatment option for patients with HCC. However, only about one-fifth of patients are suitable for such primary curative treatments due to underlying liver disease or ...
Seyda Gunduz +6 more
openaire +1 more source
Radioembolization in Advanced Hepatocellular Carcinoma
Journal of Clinical Oncology, 2018The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors’ suggested management approaches.
Ahsun, Riaz +2 more
openaire +2 more sources
Radioembolization of Hepatocellular Carcinoma
Current Drug Discovery Technologies, 2010In this review paper, available data on radioembolization of unresectable hepatocellular carcinoma (HCC) using commercially available radiopharmaceuticals, respectively (131)I-Lipiodol, Therasphere (glass-microspheres) and SIRspheres (resin-microspheres) are reviewed. In the palliative setting, (131)I-Lipiodol was shown to yield response rates of 17-92%
openaire +2 more sources
Transarterial Radioembolization (TARE)
2018Transarterial radioembolization (TARE) refers to the delivery of radioactive microspheres directly into an artery that perfuses a tumor or tumor-bearing tissue. In current clinical practice, radioembolization is employed almost exclusively for liver tumors, which include primary liver tumors such as hepatocellular carcinoma, as well as metastatic ...
Ryan Hickey +2 more
openaire +1 more source
Transarterial Radioembolization: Overview of Radioembolic Devices
Seminars in Interventional Radiology, 2023Muhamad, Serhal +4 more
openaire +2 more sources
Segmental Pneumonitis after Radioembolization
Journal of Vascular and Interventional Radiology, 2018Radiation pneumonitis, although infrequent, is a dreaded complication of radioembolization (RE) with yttrium-90 ( 90 Y) microspheres (1). Only 6 cases have been reported so far (1,2). It develops when 90 Y microspheres reach the lung filter owing to circumvention of the liver sinusoidal network through the tumor or arteriovenous channels.
Bilbao, J.I. (José I.) +7 more
openaire +2 more sources
Journal of Vascular and Interventional Radiology, 2019
PURPOSE To investigate the safety of yttrium-90 radioembolization in combination with checkpoint inhibitor immunotherapy for the treatment of hepatocellular carcinoma (HCC).
C. Zhan +9 more
semanticscholar +1 more source
PURPOSE To investigate the safety of yttrium-90 radioembolization in combination with checkpoint inhibitor immunotherapy for the treatment of hepatocellular carcinoma (HCC).
C. Zhan +9 more
semanticscholar +1 more source
Radioembolization and the Cystic Artery
Journal of Vascular and Interventional Radiology, 2014Based on a review of the literature about the topic and personal experience obtained in several years performing radioembolization, if I have to answer the question posed by Prince et al (1), I will arrive at a very similar conclusion as the authors: Yes, we need to take precautionary measures with RE, as we always do when performing an interventional ...
openaire +2 more sources
Radioembolization-Induced Gastroduodenal Ulcer
The American Surgeon™, 2012Malika, Garg +3 more
openaire +2 more sources